Claire Mathiot
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Oncology top 0.5%
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Oncology 49
- Cancer Cells and Metastasis 15
- Cancer Treatment and Pharmacology 11
- Hematology 46
- Multiple Myeloma Research and Treatments 41
- Co-authors
- François‐Clément Bidard (12 shared papers)Jean‐Yves Pierga (11 shared papers)Thierry Façon (30 shared papers)Philippe Moreau (30 shared papers)Michel Attal (26 shared papers)Hervé Avet‐Loiseau (30 shared papers)Gérald Marit (18 shared papers)Wolf H. Fridman (31 shared papers)
- Journals
- Blood (23 papers)Journal of Clinical Oncology (14 papers)Cancer Research (6 papers)Annals of Oncology (5 papers)Journal of Clinical Investigation (3 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Claire Mathiot
113 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 113
- Hematology 2.1k
- Oncology 2.5k
- Cancer Research 851
- Genetics 352
- Immunology 663
Countries citing papers authored by Claire Mathiot
This map shows the geographic impact of Claire Mathiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Mathiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Mathiot more than expected).
Fields of papers citing papers by Claire Mathiot
This network shows the impact of papers produced by Claire Mathiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Mathiot. The network helps show where Claire Mathiot may publish in the future.
Co-authors
The 25 scholars most cited alongside Claire Mathiot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 399 | |
| 2 | 2010 | 311 | |
| 3 | 2008 | 308 | |
| 4 | 2009 | 281 | |
| 5 | 2010 | 280 | |
| 6 | 2011 | 226 | |
| 7 | 2009 | 212 | |
| 8 | 2009 | 196 | |
| 9 | 2013 | 159 | |
| 10 | 2010 | 121 | |
| 11 | 2002 | 120 | |
| 12 | 2009 | 115 | |
| 13 | 2010 | 109 | |
| 14 | 1994 | 106 | |
| 15 | 2008 | 105 | |
| 16 | 1995 | 98 | |
| 17 | 1998 | 97 | |
| 18 | 2010 | 96 | |
| 19 | 2002 | 90 | |
| 20 | 2015 | 80 |
About Claire Mathiot
Claire Mathiot is a scholar working on Oncology, Hematology, Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 116 papers that have together received 5.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (41 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Cancer Cells and Metastasis (15 papers), Glycosylation and Glycoproteins Research (11 papers), Protein Degradation and Inhibitors (11 papers), Cancer Treatment and Pharmacology (11 papers), T-cell and B-cell Immunology (9 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Hematology (2.1k citations), Oncology (2.5k citations), Cancer Research (851 citations), Genetics (352 citations) and Immunology (663 citations). Claire Mathiot has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include François‐Clément Bidard, Jean‐Yves Pierga, Thierry Façon, Philippe Moreau, Michel Attal, Hervé Avet‐Loiseau, Gérald Marit, Wolf H. Fridman, Suzette Delaloge and Étienne Brain. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Research, Annals of Oncology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.